california tirzepatide injections FDA approves Zepbound for weight loss Tirzepatide (Mounjaro) In Sherman Oaks

Researchers found that newer medications appear to keep patients on therapy longer, while side effects remain a major reason for discontinuation.

New study finds a lot of variation in the practice.

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound

Zolpidem (Photo credit: Wikipedia) The FDA announced this morning that it is recommending the bedtime dose of Zolpidem (brand name Ambien) be lowereddue to the risk of next-morning impairment. In a press releaseissued this morning the FDA says it recommending the change "because new data show that blood levels in some [...]

Its active ingredient is tirzepatide, a dual receptor agonist that acts on both GIP glucose-dependent insulinotropic polypeptide receptors and GLP-1 glucagon-like peptide-1 receptors

In a letter, the FDA said it needs more data to fully understand several possible risks tied to the drug, including heart and liver problems.